IHS Chemical Week

Archives :: Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Displaying 361 - 372 of 1424 stories.
May 22, 2014
Novasep (Pompey, France), a supplier of services and technologies to the life sciences industry, says that it has completed a €4-million ($5.5 million) expansion of its highly...
May 21, 2014
FDA issued a warning letter on 7 May to the active pharmaceutical ingredient (API) and finished pharmaceutical manufacturing facilities of Sun Pharmaceutical Industries (Sun Pharma...
May 20, 2014
SAFC Commercial, the custom manufacturing services business unit of Sigma-Aldrich, has installed a new commercial-scale continuous-flow reactor at its Sheboygan, WI, facility with...
May 20, 2014
AstraZeneca rejects Pfizer's latest offer AstraZeneca has rejected Pfizer's latest offer to buy AstraZeneca. Pfizer says its offer, which values AstraZeneca at £69 billion ($116...
May 20, 2014
Pharmaceutical company Relypsa (Redwood City, CA) says that it has entered into a multi-year commercial manufacturing and supply agreement with DSM Fine Chemicals for the active...
May 18, 2014
Pfizer said on Sunday that it has raised its offer for AstraZeneca to £69 billion ($116 billion), and said it would walk away if AstraZeneca does not accept the offer. The...
May 17, 2014
Abbott Laboratories said on Friday that it has signed a definitive agreement to acquire Latin American pharmaceutical company CFR Pharmaceuticals (Santiago), more than doubling the...
May 13, 2014
Specialty chemicals and food ingredients distributor IMCD Group (Rotterdam) says that it has signed an agreement to acquire the agency business of Jucker Pharma (Stockholm), a...
May 13, 2014
Teva’s API business reports fall in sales The active pharmaceutical ingredient (API) business of Teva Pharmaceutical Industries (PetaŠł• Tiqwa, Israel) reports a 6.7% fall in...
May 10, 2014
Merck KGaA (Darmstadt, Germany) plans to invest €100 million ($137.6 million) this year in biosimilars, a new business being developed by its Merck Serono unit. In addition, Merck...
May 8, 2014
Codexis (Redwood City, CA), a developer of biocatalysts for the pharmaceutical and fine chemical industries, reports a net loss of $6.37 million in the first quarter of 2014 compared...
May 6, 2014
The oral solid-dosage form (OSDF) excipients market, which is valued at nearly $2.3 billion in the United States, Europe, India, and China, is growing sustainably on a global scale...
Pages: « Previous  28 29 30 31 32 33 34 35 36 [37] 38 39 40 41 42 43 44 45 46 Next »




RSS Follow us on Twitter Join us on LinkedIn Like us on Facebook Youtube channel
contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa